VYNE Therapeutics (VYNE) Q2 2023 Earnings

14AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-3.24
-2.21
-1.19
-0.16

Details

Expected EPS
-1.99
Actual EPS
-2.82
Surprise EPS
-0.83
Surprise Percent
+41.71%

Description

VYNE Therapeutics (VYNE) has reported earnings of -2.82 per share for Q2 2023.

0 Comments

Share your thoughts